Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Psoriasis
Interventions
BIOLOGICAL

alefacept

IM injection

Trial Locations (5)

1000

First Municipal Hospital for Active Treatment - Sofia, Sofia

1001

Skin and STD Clinical Centre, Riga

1004

Department of Dermatology No.17, Children Clinical Hospital, Riga

40217

Physicians Skin Care, PLLC, Louisville

92123

Pediatric and Adolescent Dermatology, San Diego

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY